DEXCOM INC Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Dexcom Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2013 to Q3 2024.
  • Dexcom Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 410M shares, a 3.89% decline year-over-year.
  • Dexcom Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 426M shares, a 0.47% decline from 2022.
  • Dexcom Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 428M shares, a 0.3% decline from 2021.
  • Dexcom Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 429M shares, a 2% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 410M -16.6M -3.89% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-24
Q2 2024 417M -14.7M -3.41% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-25
Q1 2024 417M -1.8M -0.43% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-25
Q4 2023 426M -2M -0.47% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-08
Q3 2023 427M +1M +0.24% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-24
Q2 2023 432M +10.1M +2.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-25
Q1 2023 419M -10.2M -2.38% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-25
Q4 2022 428M -1.3M -0.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-08
Q3 2022 426M -4.5M -1.05% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-26
Q2 2022 421M -5.7M -1.34% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-27
Q1 2022 429M +324M +310% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-27
Q4 2021 429M +8.4M +2% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-08
Q3 2021 430M +331M +332% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-27
Q2 2021 427M +330M +340% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-28
Q1 2021 105M +10.5M +11.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-28
Q4 2020 420M +328M +355% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-09
Q3 2020 99.5M +7M +7.57% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-28
Q2 2020 97M +5.9M +6.48% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 94.1M +3.8M +4.21% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
Q4 2019 92.3M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-14
Q3 2019 92.5M +2.2M +2.44% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-27
Q2 2019 91.1M +1.7M +1.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-28
Q1 2019 90.3M Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-28
Q3 2018 90.3M +3.6M +4.15% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 89.4M +2M +2.29% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-31
Q3 2017 86.7M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 87.4M +3.8M +4.55% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-01
Q2 2016 83.6M +4M +5.03% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-01
Q3 2015 80.5M +4.4M +5.78% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-04
Q2 2015 79.6M +4.3M +5.71% Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-05
Q3 2014 76.1M +4.7M +6.58% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 75.3M +4.4M +6.21% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q3 2013 71.4M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 70.9M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.